SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is generating significant momentum following its landmark marketing approval in Japan, which has prompted analysts to raise price targets to $12. Investors are actively discussing the company's strong cash position and the upcoming U.S. clinical trial milestones, framing the stock as a compelling, undervalued opportunity in the oncology sector.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is capturing significant community attention as it secures strategic government contracts and deepens its collaboration with NVIDIA, leading investors to view it as a compelling, undervalued alternative to other quantum stocks. While some express frustration with recent price volatility and de-SPAC pressure, many are actively accumulating shares based on a long-term conviction in the companys debt-free balance sheet and its pivotal role in national security and AI integration.

VanEck ETF Trust - VanEck Agribusiness ETF

VanEck Agribusiness ETF

Investors are increasingly rotating into the agricultural sector, viewing agribusiness as a defensive play that is showing signs of a structural breakout. The community is actively discussing the sector's potential to benefit from fresh inflows and long-term food demand, with many highlighting agribusiness as an undervalued, unloved trade that is finally beginning to gain momentum.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the online community debate the stock's volatility alongside the President's recent high-stakes ultimatum regarding Iranian power infrastructure. Sentiment remains deeply polarized, with active discussions centering on the company's financial health, the impact of escalating geopolitical tensions on energy markets, and the broader political controversy surrounding the administration's policy decisions.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure as investors react to a federal jury verdict finding Elon Musk liable for misleading shareholders, coupled with broader market volatility and concerns over the company's ambitious but costly AI and robotics initiatives. The community remains deeply polarized, with many traders speculating on further downside toward key support levels while others debate the long-term viability of the stock amid ongoing regulatory scrutiny and the company's pivot toward high-expenditure tech projects.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending due to persistent, high-profile acquisition rumors linking the French biotech to potential suitors like Eli Lilly and AstraZeneca, fueled by reports from investigative outlets and strong institutional interest. The community remains focused on the company's robust ulcerative colitis drug pipeline and the potential for a significant buyout premium, keeping trading volume high as investors monitor for official confirmation of a deal.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco Corp is surging following the announcement of an $80 billion strategic partnership with Brookfield and the U.S. government to accelerate the deployment of Westinghouse nuclear reactors. The community is actively discussing this massive infrastructure commitment as a critical long-term catalyst for meeting the ballooning energy demands of AI data centers.

Invesco DB Multi-Sector Commodity Trust - Invesco DB Agriculture Fund

Invesco DB Agriculture Fund

The Invesco DB Agriculture Fund is trending as investors weigh persistent global supply chain disruptions and geopolitical instability against the potential for demand destruction in food commodities. Market participants are intensely focused on how persistent inflation, exacerbated by rising fertilizer and energy costs, will continue to impact the agriculture sector's profitability.

Global X Funds - Global X Silver Miners ETF

Global X Silver Miners ETF ($SIL) is trending as investors react to a significant silver supply-demand deficit and increasing industrial usage in sectors like AI and electric vehicles. The community is actively debating the sustainability of the recent rally, with many traders focusing on the structural decoupling of physical silver prices from paper-contract markets, while others monitor for signs of a technical correction following the rapid price appreciation.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is gaining significant momentum as investors pivot toward defense-tech and earth-observation stocks, bolstered by its new prime contractor status under the Pentagon's SHIELD program. The community is actively discussing the company's expanding backlog, its strategic AI partnerships with industry giants like NVIDIA and Google, and its growing importance in global national security as a key source of real-time geospatial intelligence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks Research Downgrades Gyre Therapeutics (NASDAQ:GYRE) to Strong Sell

Zacks Research lowered shares of Gyre Therapeutics from a "hold" rating to a "strong sell" rating in a report on Monday...

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 8.2% - Time to Sell?

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 8.2% - Should You Sell...

Gyre Therapeutics (NASDAQ:GYRE) Announces Earnings Results

Gyre Therapeutics (NASDAQ:GYRE - Get Free Report) posted its earnings results on Thursday. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04). The...

Gyre Therapeutics (NASDAQ:GYRE) Downgraded by Wall Street Zen to Hold

Wall Street Zen cut Gyre Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Down - Should You Sell?

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Down - What's Next...

Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates

Gyre Therapeutics, Inc. (GYRE) delivered earnings and revenue surprises of -50.00% and +2.17%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates

ADC Therapeutics (ADCT) delivered earnings and revenue surprises of +87.50% and +20.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Voyager Therapeutics (VYGR) Reports Q4 Loss, Beats Revenue Estimates

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of +15.08% and +57.97%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Gyre Therapeutics (GYRE) Expected to Announce Quarterly Earnings on Monday

Gyre Therapeutics (NASDAQ:GYRE) will be releasing its Q4 2025 earnings before the market opens on Monday, March 16. (View Earnings Report at...

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up - Time to Buy?

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up - Here's Why...

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.

GYRE
Gyre Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GYRE News

GYREGyre Therapeutics Inc